InvestorsHub Logo
north40000
Level Icon

Followers 253
Posts 17,893
Boards Moderated 0
Alias Born 01/19/2006

north40000
Level Icon

Message

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

north40000
Level Icon

north40000 My Stocks

Ticker Board News Price Change Chg% Added
AMRN Amarin Corp Plc 0.8705 0.0104 1.21% 03/03/2021
GILD Gilead Sciences Inc 65.63 0.36 0.55% 05/02/2018
My GILD Pitch: Our basis is split-adjusted $0.758/share, acquired 06-1996.GILD's Focus is on treatments for HIV, HCV, HBV, Oncology, future acquisitions. http://tinyurl.com/jva7ron; http://www.gilead.com/
https://tinyurl.com/ya7oeqms

VCEL Vericel Corp. 46.11 0.66 1.45% 04/12/2018
CDMO Avid Bioservices Inc 7.45 0.13 1.78% 01/15/2018
WFM Whole Foods Markets 11/11/2017
My WFM Pitch: We have shopped for groceries at WFM for many years. We like its quality--if you like the company's product chances are you should buy its stock. Our split-adjusted basis is $17.37. AMZN purchased WFM for $42/share in 2017.
Ariad Pharmaceuticals Inc fka ARIA 02/15/2017
My Pitch: Our basis is $2.29. I am confident of share price increase predicated on upcoming catalysts at FDA, recent financing and potential buy-out. Doubled holdings on 11/07/2013. Takeda agrees to acquire ARIA: $24/share
http://tinyurl.com/jrahcmc
Ocata Therapeutics Inc fka OCAT 03/04/2016
SBUX Starbucks Corporation 88.38 0.54 0.61% 03/04/2016
My SBUX Pitch: Our split-adjusted bases:$2.19 and $2.984.I look forward to its continued global expansion, particularly in Europe, China, Vietnam, Italy and India. Founder Howard Schultz has led turn-around in U.S. Recent earnings and developments: https://news.starbucks.com/
CPRX Catalyst Pharmaceutical Partners 14.945 0.265 1.81% 09/02/2014
AMLN Amylin Pharmaceuticals Inc. 08/28/2012
My AMLN Pitch: One of leading T2Diabetes and obesity-focused companies. Underwent takeover examination by >5 companies [AZN,NVS,BMY,SNY,MRK], reported bids >$25/share. BMY/AZN TO @$31/share expired 08/07. I accumulated in many tranches since 1995; basis for 85% of holdings is $6.60/share. Shares now gone @$31.
SGEN Seagen Inc 0 0 0.00% 06/14/2012
IBM International Business Machines 166.38 -2.53 -1.50% 01/24/2012
JNJ Johnson and Johnson 146.35 -0.47 -0.32% 08/12/2010
INSM Insmed Inc 24.8 -0.12 -0.48% 08/12/2010
* Market data is delayed 15-20 minutes.